Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model

An Author Correction to this article was published on 15 October 2019

This article has been updated


Survivors of Ebola virus infection may become subclinically infected, but whether animal models recapitulate this complication is unclear. Using histology in combination with immunohistochemistry and in situ hybridization in a retrospective review of a guinea pig confirmation-of-virulence study, we demonstrate for the first time Ebola virus infection in hepatic oval cells, the endocardium and stroma of the atrioventricular valves and chordae tendinae, satellite cells of peripheral ganglia, neurofibroblasts and Schwann cells of peripheral nerves and ganglia, smooth muscle cells of the uterine myometrium and vaginal wall, acini of the parotid salivary glands, thyroid follicular cells, adrenal medullary cells, pancreatic islet cells, endometrial glandular and surface epithelium, and the epithelium of the vagina, penis and, prepuce. These findings indicate that standard animal models for Ebola virus disease are not as well-described as previously thought and may serve as a stepping stone for future identification of potential sites of virus persistence.


Ebola virus disease (EVD) is a severe and frequently lethal affliction of humans caused by infection with any of three members of the mononegavirus family Filoviridae: Bundibugyo virus (BDBV), Ebola virus (EBOV), and Sudan virus (SUDV). A fourth virus, Taï Forest virus (TAFV), has thus far caused only a single reported human infection, which was nonlethal1. EVD is an exotic disease with case numbers rarely surpassing the lower hundreds1; however, from 2013–2016, EBOV caused an EVD outbreak in Western Africa encompassing 28,616 infections and 11,310 deaths in Guinea, Liberia, and Sierra Leone2. Long term sequelae in individual survivors of acute EVD and the similar Marburg virus disease (MVD) and filovirus persistence followed by disease relapse or sexual transmission had been reported before this outbreak3,4,5,6,7,8. However, observations during and following the Western African EVD outbreak suggest that sequelae and filovirus persistence may be common events9. Reported sequelae include arthralgia, cardiac valvulopathy, parotid gland inflammation, peripheral paresthesia or dysesthesia, and gastrointestinal motility disorders10,11,12,13,14. Semen may contain detectable EBOV RNA for more than 500 days following recovery, and EBOV RNA has been detected in breast milk of a subclinically infected mother15,16. Replicating EBOV has been isolated from the cerebrospinal fluid of an EVD survivor suffering a disease relapse and from the aqueous humor of the eye of another survivor17,18. Sexual EBOV transmission from EVD survivors to partners months after infection also has been documented19,20.

Only 26 EVD outbreaks (16 of them due to EBOV infection) have been recorded since the initial discovery of EVD-causing viruses in 1976, and excluding the Western African outbreak, no EVD outbreak has encompassed more than 500 cases1. Because the natural host reservoirs of EVD-causing filoviruses remain to be identified, the periodic introductions of these viruses into the human population are unpredictable and unpreventable. In conjunction with the high case-fatality rate of EVD1, performance of meaningful clinical studies is challenging. Therefore, characterization of EVD pathogenesis and primary development and evaluation of medical countermeasures largely relies on experimental infections of animal models. Predominantly, these models include nonhuman primates (crab-eating, aka cynomolgus, macaques [Macaca fascicularis] and rhesus monkeys [Macaca mulatta]), and, after virus adaptation, rodents (laboratory mice, guinea pigs [Cavia porcellus], and Syrian hamsters [Mesocricetus auratus])21,22. Recently, domestic ferrets (Mustela putorius furo) have been identified as novel EVD animal models not requiring virus adaptation23,24,25. However, with the exception of one study demonstrating EBOV persistence in apparently healthy rhesus monkey survivors of EBOV-induced disease26, development of sequelae and/or viral persistence, and demonstration of sexual transmission, remains to be recapitulated in animal models.

Based on in vitro results of studies of EBOV persistence in cell culture27, we speculate that EBOV may establish in vivo persistent infections in any entry-permissive cell type, rather than only in immunoprivileged sites such as brain, eyes, and testes. Before this speculation can be tested, validating the reported tissue and cell tropism of EBOV in animal models is imperative. We chose the guinea pig model, as the model is considered to be more stringent than the laboratory mouse model and less ethically, financially, and logistically burdensome than nonhuman primates models21,22. The guinea pig model is considered well-characterized and is actively used for transmission and medical countermeasure evaluation studies. EBOV infection has been previously demonstrated in a wide variety of guinea pig tissues and cell types, including cells of the monocyte or macrophage system, hepatocytes, fibroblastic reticular cells, interstitial fibroblasts, adrenal cortical cells, ovarian thecal cells, endothelial cells, endometrial stromal cells, and cells of the urothelium28,29,30,31,32,33,34,35,36,37,38,39. In a retrospective histologic review of tissues from EBOV-infected guinea pigs, in combination with immunohistochemistry and in situ hybridization, we demonstrate that EBOV infection of several tissues and numerous cell types has been overlooked.


All 30 guinea pigs intraperitoneally infected with 1 of 3 EBOV doses (n = 10/group) developed illness. Seven guinea pigs (3 in 10-PFU group, 2 in 100-PFU group, and 2 in the 1,000-PFU group) succumbed to EVD and were not necropsied due to autolysis. The remaining 23 guinea pigs (7 in the 10-PFU group, 8 in the 100-PFU group, and 8 in the 1,000-PFU group) were necropsied, and specific tissues were collected for histology (see Supplemental Table 1 for animal-by-animal breakdown of sex, inoculation dose, day of euthanasia, and relevant pathology findings). All 23 guinea pigs examined histologically had extensive hepatocellular and lymphoid necrosis consistent with previous descriptions of guinea pig-adapted Ebola virus infection in this model30,31. IHC and ISH staining confirmed hepatocytes, monocytes and macrophages as major targets of EBOV infection.

Table 1 Experimental endpoint criteria.


The majority of findings were consistent with previous reports30,31, including widespread hepatocyte and Kupffer cell infection and necrosis, with variable dystrophic mineralization. In contrast to the rhesus monkey model of EVD, viral intracytoplasmic inclusion bodies (ICIB) were large and numerous. Livers were collected from 6/7 guinea pigs in the 10-PFU, 8/8 in the 100-PFU, and 8/8 in the 1,000-PFU group (Supplemental Table 1). In 7 of 22 livers examined (samples from 1 guinea pig were not available), multifocal minimal- to-moderate oval cell hyperplasia originated in the biliary ductules and extended into lobules. Small basophilic cells with a high nucleus:cytoplasm ratio formed parallel streams and duct-like structures, consistent with International Harmonization of Nomenclature and Diagnostic criteria (INHAND)40. Viral ICIB were frequently observed within oval cells (Fig. 1a) with IHC and ISH positive signals (Fig. 1b,c). Oval cells were present in animals from all three dosage groups, with the occurrence of such cells loosely correlating with the infectious inoculum: 1 of 6 guinea pigs in the 10-PFU group; 1 of 8 in the 100-PFU group; and 5 of 8 in the 1000-PFU group. Oval cells were only present in animals necropsied at d 8 or 9 post-inoculation. No viral infection of biliary ductules was present as judged by histology, IHC, or ISH.

Figure 1

EBOV infection of the liver and heart. (a) Oval cell infection of the liver. Parallel streams of basophilic oval cells form duct-like structures adjacent to a portal triad, with frequent large eosinophilic toamphiphilic intracytoplasmic inclusion bodies (arrows, H&E). (b) Proliferating oval cells, hepatocytes, Kupffer cells, and intravascular monocytes (EBOV VP40 IHC: DAB chromogen and hematoxylin). (c) Oval cells, hepatocytes, and Kupffer cells (EBOV NP ISH: fast red chromogen and hematoxylin). (d) Valvular endocarditis of tricuspid valve cusp. Degeneration and necrosis of surface (atrialis) endocardial cells and stromal cells of the spongiosa, with infiltrating macrophages and frequent large eosinophilic to amphiphilic intracytoplasmic inclusion bodies (arrows, H&E). (e) Endocardial cells, stromal cells, and macrophages (EBOV VP40 IHC: DAB chromogen and hematoxylin). (f) Endocardial cells, stromal cells, and macrophages (EBOV NP ISH: fast red chromogen and hematoxylin).


Cross-sections through one or both ventricles were collected from 22 of 23 guinea pigs (samples from 1 guinea pig were not available), with variable inclusion of atrioventricular valves and associated chordae tendinae; semilunar valves were not sampled. In all 3 examined tricuspid valves (one each from the 10-, 100-, and 1,000-PFU groups) and both mitral valves (one each from the 100- and 1000-PFU groups), viral ICIB were present in the stromal spindled fibroblasts of the spongiosa and surface endocardium of atrialis of the atrioventricular valves (Fig. 1d). Sometimes viral ICIBs were associated with infiltrating macrophages and apoptotic and necrotic cellular debris (Fig. 1d). EBOV infection of the fibroblasts was confirmed by IHC and ISH (Fig. 1e,f). Viral ICIBs were also present in the stromal cells of the chordae tendinae of the tricuspid valve in 8 of 11 examined guinea pigs and of the chordae tendinae of the mitral valve of 16 of 17 examined guinea pigs. In three of 22 guinea pigs, very rare individual cardiomyocytes were noted that contained ICIB, with confirmation by IHC.

Nerves and ganglia

From samples available from 7 guinea pigs, the paradrenal or mesenteric ganglia and nerves were collected with adrenals or mesenteric lymph nodes, respectively. Multifocal mild to rarely moderate histiocytic inflammation (ganglioneuritis) was noted in 5 of 7 animals, with mild ganglion cell degeneration or loss and satellite cell hyperplasia (nodules of Nageotte). Viral ICIB were present within infiltrating macrophages, and occasional satellite cells, neurofibroblasts, and Schwann cells (Fig. 2a), with EBOV-positive labeling by IHC and ISH (Fig. 2b,c). No evidence of neuronal infection was observed in any sample. Multiple myelinated medium and large mesenteric nerves and other peripheral nerves were characterized by rare ICIB within neurofibroblasts, Schwann cells, and infiltrating macrophages (Fig. 2d). Infected cells, endothelial cells, and intravascular plasma were labeled by IHC and ISH (Fig. 2e,f). In a single guinea pig, multiple digestion chambers consisting of segmental expansion of the axon sheath by lipid laden macrophages were present in a single large axillary/brachial nerve in the absence of ICIB. Unfortunately, the nerve was lost on re-sectioning.

Figure 2

EBOV infection of paradrenal ganglia and peripheral medium myelinated nerves. (a) Low numbers of macrophages infiltrate between ganglion cells in the paradrenal ganglion. Viral intracytoplasmic inclusion bodies (arrows) are present within satellite cells, neurofibroblasts, Schwann cells, and macrophages (H&E). (b) Satellite cells, neurofibroblasts, Schwann cells, and macrophages, and intravascular plasma (EBOV VP40 IHC: DAB chromogen and hematoxylin). (c) Satellite cells, neurofibroblasts, Schwann cells, and macrophages in the ganglion (EBOV NP ISH: fast red chromogen and hematoxylin). (d) Viral intracytoplasmic inclusion bodies (arrows) are present within neurofibroblasts and Schwann cells within a nerve, with low numbers of perivascular infiltrating macrophages (bottom) (H&E). (e) Rare infected Schwann cells and neurofibroblasts within a myelinated nerve (EBOV VP40 IHC: DAB chromogen and hematoxylin). (f) Low numbers of Schwann cells, neurofibroblasts, and infiltrating macrophages within a myelinated nerve (EBOV NP ISH: fast red chromogen and hematoxylin).

Genital tract

Of the 12 EBOV-infected female guinea pigs for which slides were available, uterine bodies were collected from 3 animals, uterine cervices and vaginas from 3 animals, and vaginas from 2 animals. In all specimens examined except one vagina, rare-to-frequent viral ICIB were present within smooth muscle cells, with scant apoptosis, necrosis, or histiocytic inflammation (Fig. 3a–c). In two sections of uterus and two sections of vagina, immunolabeling of rare small clusters of surface and glandular epithelial cells was positive (Fig. 4a,b). Consistent with previous reports, endometrial stromal cells and interstitial fibroblasts, macrophages and endothelial cells contained ICIB and stained positively for EBOV by IHC and ISH30,31.

Figure 3

EBOV infection of the uterus. (a) Numerous large eosinophilic to amphiphilic intracytoplasmic inclusion bodies (arrows) within smooth myocytes, with scattered apoptosis and necrosis (H&E). (b) Smooth myocytes and endometrial stromal cells (EBOV VP40 IHC: DAB chromogen and hematoxylin). (c) Myometrial smooth muscle cells (EBOV NP ISH: fast red chromogen and hematoxylin).

Figure 4

EBOV infection of the vagina, penis, and prepuce. (a) Rare small clusters of infected metestrus epithelial cells in the vagina (EBOV VP40 IHC: DAB chromogen and hematoxylin). (b) Endometrial gland epithelial cells, as well as stromal cells and macrophages, of the uterine body (EBOV VP40 IHC: DAB chromogen and hematoxylin). (cf) Penis and prepuce. (c) Scattered small clusters of keratinocytes within the stratified squamous cornifying epithelium with large viral intracytoplasmic inclusions (arrows). (d) In addition to stromal fibroblasts and macrophages, clusters of epithelial cells covering the penis and prepuce (EBOV VP40 IHC: DAB chromogen and hematoxylin). (e) Higher magnification of subfigure. (d,f) Clusters of infected epithelial cells. (EBOV GP IHC: DAB chromogen and hematoxylin).

The penis and prepuce was collected from a single male guinea pig (post-inoculation day 9, 100-PFU group). Several small clusters of spinous layer epithelial cells in the prepuce exhibited cytoplasmic vacuolation and contained viral ICIB (Fig. 4c). Scattered apoptosis and necrosis of adjacent cells were noted. Discrete vertical columns of EBOV-positive cells (IHC) were present in the non-haired skin of both the penis and prepuce (Fig. 4d–f).

Salivary glands

Salivary glands were collected incidentally with the mandibular lymph nodes from some animals. In most salivary glands, very low numbers of macrophages and fibroblasts containing ICIB were present in the interstitium surrounding the acini and ducts. In 8 of 10 parotid glands examined, multifocal mild-to-moderate acinar cell necrosis with histiocytic inflammation was observed (Fig. 5a). Immunostaining of 3 glands showed abundant EBOV antigen localized to these necrotic foci and in viable and degenerate acinar cells (Fig. 5b). ISH results confirmed these IHC findings (Fig. 5c). Rare scattered acinar cell necrosis without ICIB was noted in 1 of 8 submandibular glands examined. Rare ductal cell necrosis in the absence of ICIB was observed in 2 of 6 sublingual glands available for review.

Figure 5

EBOV infection of the salivary glands and thyroid. (a) Necrotizing adenitis of parotid salivary gland. Focal acinar cell necrosis with rare large eosinophilic to amphiphilic intracytoplasmic inclusion bodies (arrows, H&E). (b) Infiltrating macrophages, interacinar fibroblasts, and viable and degenerate acinar cells (EBOV VP40 IHC: DAB chromogen and hematoxylin). (c) Infected acinar cells, macrophages and fibroblasts (EBOV NP ISH: fast red chromogen and hematoxylin). (d) Degeneration, sloughing, and necrosis of follicular epithelium, with rare large eosinophilic to amphiphilic intracytoplasmic inclusion bodies (arrows) in follicular cells and infiltrating macrophages (H&E). (e) Infected follicular cells, intra-follicular and interstitial macrophages, and interstitial stromal cells (EBOV VP40 IHC: DAB chromogen and hematoxylin). (f) Infected follicular epithelium and interstitial cells (EBOV NP ISH: fast red chromogen and hematoxylin).


Thyroid tissues were collected incidentally with the trachea and esophagus from 4 of 23 guinea pigs examined. In all glands, very low numbers of macrophages and fibroblasts containing ICIB were present in the interstitium surrounding the follicles. In 3 of the 4 thyroid tissues available, multifocal mild-to-moderate follicular cell degeneration and necrosis were noted with low numbers of infiltrating viable and degenerate macrophages within the follicles (Fig. 5d). Both macrophages and follicular cells contained ICIB and were immunopositive, with occasional granular staining of the colloidal material similar to the staining of plasma within blood vessels (Fig. 5e). Macrophages, interstitial fibroblasts and follicular epithelial cells were also positive for EBOV RNA by ISH (Fig. 5f).

Adrenal Glands

Consistent with previous reports on the guinea pig model, adrenal cortical cells and sinusoidal macrophages were frequently infected30,31,33,41. Low numbers of chromaffin cells (less than 5%) with viral ICIB were present in the adrenal medullas from 5 of the 18 guinea pigs from which they were collected (Fig. 6a–c). Glassy eosinophilic “hyaline globules” within the cytoplasm of medullary cells were noted more frequently than viral ICIB42.

Figure 6

EBOV infection of adrenal medulla and pancreas. (a) Occasional large viral inclusions (arrows) within chromaffin cells (H&E). (b) Chromaffin cells (EBOV VP40 IHC: DAB chromogen and hematoxylin). (c) EBOV-infected chromaffin cells (EBOV NP ISH: fast red chromogen and hematoxylin). (d and e) EBOV-infected endocrine cells of the Islets of Langerhans, exocrine acinar cells, and interstitial fibroblasts and macrophages (d: EBOV VP40 IHC: DAB chromogen and hematoxylin, e: EBOV NP ISH: fast red chromogen and hematoxylin).


Of the 23 guinea pigs available, 6 pancreata were examined. Very low numbers of macrophages and fibroblasts containing ICIB were noted in the interstitium surrounding acini and ducts, consistent with previous reports30. The presence of ICIB and positive EBOV IHC and ISH signals within acinar cells were also expected. In 5 of the 6 pancreata, low numbers of endocrine cells within the islets of Langerhans contained ICIB and stained positively by IHC and ISH, frequently occurring in small clusters (Fig. 6d,e). Islets were not uniformly affected, with some islets containing no infected cells while rare islets had up to 20% EBOV infection.


The gross and histologic lesions of experimental EBOV-induced disease in nonhuman primate and rodent models are considered largely identical with that of natural human infections30,31,43. However, this presumed identity may be incorrect because, for instance, only very few autopsies of EVD victims have been performed43. Likewise, despite the long history of using guinea pigs in filovirus research28,29,30,31,32,33,34,35,36,37,38,39, many manuscripts do not include histology or are limited to the evaluation of livers and spleens. Only a handful of studies have been performed to thoroughly characterize EBOV cell tropism in the guinea pig using histology, ultrastructural evaluation and/or IHC, and almost none have utilized ISH to detect viral genome30,31,33,41. In our study, we discovered that EBOV infects and likely replicates in numerous tissues and cell types previously not known to be involved in the pathogenesis in the guinea pig model.

Although not previously described in filovirus infection models, the finding of oval cell hyperplasia was not unexpected because of the extensive hepatocellular necrosis subsequent to EBOV infection. Oval cells, derived from the terminal ductule epithelial cells of the canal of Hering, are bipotential progenitor cells that may differentiate to biliary cells or hepatocytes40. Oval cells may be induced with any liver injury, including toxins and infections. However, we were surprised by the presence of EBOV RNA and antigen in oval cells, which could potentially affect both EBOV clearance and hepatic parenchymal regeneration in EVD survivors.

EBOV infection and inflammation of the atrioventricular valves and chordae tendinae of the heart was also unexpected, but could possibly explain valvulopathy in survivors, either as a result of inflammation and scarring or of autoimmune disease. Similarly, infection of the chordae tendinae could predispose to rupture of the tendinae, resulting in atrioventricular valve prolapse. Infection of the atrial myocardium and vascular endothelium and tunica media has been previously described, but whether valves were included in previous examinations is unclear30. Demonstration of abundant viral antigen in the endocardium (NOS) has been reported in fatal acute infections in humans43.

EBOV infection of the supporting cells of the peripheral ganglia and nerves, with attendant inflammation, is intriguing, as the nature of neurologic impairment in EVD survivors is hotly debated17,26,44,45. Damage to these neural supporting cells, with a pro-inflammatory resolution, could conceivably lead to long-term nerve or ganglion damage, manifesting as altered sensory inputs or dysautonomia. Therefore, prospective studies of a survivor model of EVD, once established, should include thorough sampling of the peripheral nervous system to test this hypothesis.

Infection of ovarian thecal cells and stromal cells and macrophages of the ovary, oviduct, and uterine endometrium has been described previously in the guinea pig model of EVD and MVD30,46. Infection of smooth myocytes of the vascular tunica media has also been described30. Thus, the finding of smooth myocyte infection in the guinea pig uterus, although novel, was not entirely surprising. Although a minor feature, epithelial cell infection of the endometrium, vagina and penis/prepuce is highly interesting vis-à-vis potential sexual transmission of virus during acute subclinical or prodromal infection4,19,20. Other mucosal epithelia such as those of the tongue and esophagus have been previously demonstrated by others to be infected30,32.

The high incidence of EBOV infection and inflammation of the parotid salivary gland is significant, as saliva is known to contain the virus in acutely infected and recently convalescent individuals, and inflammation of the parotid gland is a documented sequela of disease in survivors47. The preference of EBOV for the parotid gland over the submandibular and sublingual glands may explain negative findings in a previous study, in which the specific salivary gland(s) examined was/were not reported31. Preferential infection of the parotid salivary gland has been described for other viruses, including a rat polyomavirus and mumps virus (MuV; Mononegavirales: Paramyxoviridae: Mumps rubulavirus)48,49,50.

With the exception of the adrenal cortex, infection of the endocrine system by EBOV has received little attention30,31,33,41. EBOV infection of the thyroid follicles and pancreatic islets has been described in rhesus monkeys with a prolonged clinical course, and previous guinea pig studies have reported virus without lesions in the thyroid interstitium30,51. Infection of the pancreatic islets and adrenal cortex and medulla has been reported during acute Marburg virus infection in rhesus monkeys and humans52,53. Virally-mediated destruction of these tissues could potentially predispose to autoimmune disease. While endocrine disorders have not been specifically reported among EVD survivors, disease presentation can be protean, and diagnosis difficult.

Investigations to see whether the infected tissues and cell types identified in our study also are infected in other animal models of EVD and whether filoviruses other than EBOV mimic the observed tropism in the various animals will be interesting. Discrepancies could possibly explain the differences between the filovirus disease animal models in terms of possible routes of infection, incubation period, presence or absence of individual clinical signs, lethality, and efficacy of candidate medical countermeasures. That said, our study has several limitations. First, we retrospectively analyzed tissues collected during a standard EBOV confirmation-of-virulence experiment. Thus, none of the examined tissues were target tissues for collection. Instead, the tissues were collected incidentally with other tissues expected to produce typical lesions of EBOV infection (e.g., liver, lymphoid organs, adrenal cortex), resulting in non-uniform sampling. A more thorough guinea pig study therefore ought to be performed with the sole focus to identify all EBOV target cells in vivo. Second, none of the collected tissues were analyzed by ISH for the presence of EBOV antigenomes, thereby proving EBOV replication, nor were they examined by transmission electron microscopy or for virus titers. This latter omission may have contributed to our limited ability to make correlations between infectious inoculum dose and lesion development. At this point, we therefore do not know whether the infection of the various newly identified EBOV-susceptible cell types truly leads to production of progeny virions, and consequently we cannot speculate about how much our findings truly contribute to pathogenesis. However, results of our study indicate that the pathology of filovirus infections in animal models is much less understood than previously appreciated, and that multiple opportunities may exist for filoviruses to establish cryptic and/persistent infections throughout the infected body.

Materials and Methods

Animals and virus

Fifteen male and 15 female Hartley guinea pigs (Cavia porcellus, Crl:HA, Charles River Laboratories, Wilmington, MA, strain code 051) were acclimatized to the Maximum Containment (Biosafety Level 4) Laboratory at the US National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)/Division of Clinical Research (DCR)/Integrated Research Facility at Fort Detrick (IRF-Frederick). The guinea pigs were randomized to one of three dosage groups (n = 10/group) and infected by the intraperitoneal route with guinea pig-adapted Ebola virus/UTMB/C.porcellus-lab/COD/1976/Yambuku-Mayinga-GPA (BioSample ID: SAMN05755726; henceforth EBOV), receiving the targeted doses of 10, 100, or 1,000 PFU, respectively.

All work with infectious virus was conducted in a Maximum Containment (Biosafety Level 4) Laboratory at the IRF-Frederick that is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International. All animal experiments were performed in accordance with animal study protocols approved by a DCR Animal Care and Use Committee. Protocols were compliant with the US Department of Agriculture Animal Welfare Act regulations and the US Public Health Service Policy on the Humane Care and Use of Laboratory Animals and adhered to the recommendations stated in The Guide for the Care and Use of Laboratory Animals.

Twenty-three of the 30 guinea pigs were humanely euthanized in accordance with defined experimental endpoints (Table 1) between d 7 and 9 post-exposure, and gross necropsy was performed by one of two American College of Veterinary Pathologists (ACVP) diplomate veterinary pathologists (SY and LH). Seven guinea pigs succumbed to disease and were not necropsied due to autolysis. Tissues were fixed for 72 h in 10% neutral buffered formalin before automated processing in a Tissue-Tek VIP-6 vacuum infiltration processor (Sakura Finetek USA, Torrance, CA) followed by paraffin embedding with a Tissue-Tek model TEC (Sakura). Slides were cut on a Leica model 2245 microtome at 4 µm, stained with hematoxylin and eosin (H&E) and coverslipped. Slides were examined by a single ACVP diplomate veterinary pathologist (TKC) blinded to intervention. All images were captured with a Leica DM3000 microscope and DFC 500 digital camera using Leica Application Suite version 4.10.0 (Leica Microsystems, Buffalo Grove, IL).


EBOV immunohistochemistry (IHC) was performed with mouse anti-EBOV matrix protein (VP40) antibody (1:1500; 3G5, catalog 0201–016; IBT Bioservices, Rockville, MD) or rabbit anti-EBOV glycoprotein (GP1,2) antibody (1:14,000; catalog 0301-015; IBT Bioservices), followed by biotinylated anti-mouse (catalog 115-065-166, Jackson Immunoresearch Laboratories, West Grove, PA) or anti-rabbit secondary antibody (catalog 111-065-144, Jackson Immunoresearch Laboratories), and an avidin-biotin peroxidase tertiary antibody (catalog PK-6100; Vector Laboratories, Burlingame, CA). Staining was visualized with 3,3′-diaminobenzidine (DAB) chromogen (catalog BDB2004L; Biocare Medical, Concord, CA) and counterstained with hematoxylin.

In Situ Hybridization

EBOV RNA in situ hybridization (ISH) in formalin-fixed, paraffin-embedded (FFPE) tissues was performed using the RNAscope 2.5 high definition (HD) RED kit (Advanced Cell Diagnostics, Newark, CA) according to the manufacturer’s instructions26. Briefly, 20 ZZ probe pairs targeting the genomic EBOV nucleoprotein (NP) gene were designed and synthesized by Advanced Cell Diagnostics (catalogue 448581). After deparaffinization with xylene, a series of ethanol washes and peroxidase blocking, sections were heated in Antigen Retrieval Buffer (Advanced Cell Diagnostics) and then digested by proteinase K (Advanced Cell Diagnostics). Sections were exposed to ISH target probe and incubated at 40 °C in a hybridization oven (HybEZ™, Advanced Cell Diagnostics) for 2 h. After rinsing, the ISH signal was amplified using company-provided Pre-amplifier and Amplifier conjugated to alkaline phosphatase (AP) and incubated with a red substrate-chromogen solution for 10 min at room temperature. Sections were then counterstained with hematoxylin, air-dried, and coverslipped.

Data availability

Digitally scanned slides will be made available upon request.

Change history

  • 15 October 2019

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  1. 1.

    Kuhn, J. H. In Harrison’s principles of internal medicine Vol. 2 (eds Dennis L. Kasper et al.) Ch. 234, 1323–1329 (McGraw-Hill Education, 2015).

  2. 2.

    World Health Organization. Situation report. Ebola virus disease 10 June 2016. (2016).

  3. 3.

    Nikiforov, V. V. et al. Slučaj laboratornogo zaraženiâ lihoradkoj Marburg. Ž Mikrobiol Èpidemiol Immunobiol 104–106 (1994).

  4. 4.

    Martini, G. A. & Schmidt, H. A. Spermatogene Übertragung des “Virus Marburg” (Erreger der “Marburger Affenkrankheit”). Klin Wochenschr 46, 398–400 (1968).

    Article  CAS  Google Scholar 

  5. 5.

    Baltzer, G. et al. In Verhandlungen der Deutschen Gesellschaft für Innere Medizin (ed Schlegel, B.) 1203–1206 (J. F. Bergmann Verlag, 1979).

  6. 6.

    Kalongi, Y. et al. Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo. J Infect Dis 179(Suppl 1), S15–17, (1999).

    Article  Google Scholar 

  7. 7.

    Kuming, B. S. & Kokoris, N. Uveal involvement in Marburg virus disease. Br J Ophthalmol 61, 265–266 (1977).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Kibadi, K. et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 179(Suppl 1), S13–14, (1999).

    Article  Google Scholar 

  9. 9.

    Caviness, K., Kuhn, J. H. & Palacios, G. Ebola virus persistence as a new focus in clinical research. Curr Opin Virol 23, 43–48, (2017).

    Article  Google Scholar 

  10. 10.

    Billioux, B. J. Neurological complications and sequelae of Ebola virus disease. Curr Infect Dis Rep 19, 19, (2017).

    Article  Google Scholar 

  11. 11.

    Hunt, L. & Knott, V. Serious and common sequelae after Ebola virus infection. Lancet Infect Dis 16, 270–271, (2016).

    Article  Google Scholar 

  12. 12.

    Lotsch, F., Schnyder, J., Goorhuis, A. & Grobusch, M. P. Neuropsychological long-term sequelae of Ebola virus disease survivors. A systematic review. Travel Med Infect Dis. (2017).

    Article  Google Scholar 

  13. 13.

    Mohammed, H. et al. Sequelae and other conditions in Ebola virus disease survivors, Sierra Leone, 2015. Emerg Infect Dis 23, 66–73, (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Nanyonga, M., Saidu, J., Ramsay, A., Shindo, N. & Bausch, D. G. Sequelae of Ebola virus disease, Kenema District, Sierra Leone. Clin Infect Dis 62, 125–126, (2016).

    Article  Google Scholar 

  15. 15.

    Purpura, L. J. et al. Ebola virus RNA in semen from an HIV-positive survivor of Ebola. Emerg Infect Dis 23, 714–715, (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Sissoko, D. et al. Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child. Clin Infect Dis 64, 513–516, (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Jacobs, M. et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388, 498–503, (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Varkey, J. B. et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372, 2423–2427, (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Diallo, B. et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63, 1353–1356, (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Mate, S. E. et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 373, 2448–2454, (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Nakayama, E. & Saijo, M. Animal models for Ebola and Marburg virus infections. Front Microbiol 4, 267, (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Shurtleff, A. C. & Bavari, S. Animal models for ebolavirus countermeasures discovery: what defines a useful model? Expert Opin Drug Discov 10, 685–702, (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Cross, R. W. et al. The domestic ferret (Mustela putorius furo) as a lethal infection model for 3 species of ebolavirus. J Infect Dis 214, 565–569, (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Kozak, R. et al. Ferrets infected with Bundibugyo virus or Ebola virus recapitulate important aspects of human filovirus disease. J Virol 90, 9209–9223, (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Kroeker, A. et al. Characterization of Sudan ebolavirus infection in ferrets. Oncotarget 8, 46262–46272, (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Zeng, X. et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol 2, 17113, (2017).

    Article  CAS  Google Scholar 

  27. 27.

    Calain, P., Monroe, M. C. & Nichol, S. T. Ebola virus defective interfering particles and persistent infection. Virology 262, 114–128, (1999).

    Article  CAS  Google Scholar 

  28. 28.

    Lupton, H. W., Lambert, R. D., Bumgardner, D. L., Moe, J. B. & Eddy, G. A. Inactivated vaccine for Ebola virus efficacious in guineapig model. Lancet 316/ii, 1294–1295 (1980).

    Article  Google Scholar 

  29. 29.

    Korb, G. & Slenczka, W. In Verhandlungen der Deutschen Gesellschaft für Pathologie Vol. 65 (ed Dhom, G.) 100–102 (Gustav Fischer Verlag, 1981).

  30. 30.

    Connolly, B. M. et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 179(Suppl 1), S203–217, (1999).

    Article  Google Scholar 

  31. 31.

    Cross, R. W., Fenton, K. A., Geisbert, J. B., Mire, C. E. & Geisbert, T. W. Modeling the disease course of Zaire ebolavirus infection in the outbred guinea pig. J Infect Dis 212(Suppl 2), S305–315, (2015).

    Article  CAS  Google Scholar 

  32. 32.

    Steele, K., Crise, B., Kuehne, A. & Kell, W. Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. Arch Pathol Lab Med 125, 625–630,<0625:EVGDDC>2.0.CO;2 (2001).

  33. 33.

    Pereboeva, L. A. et al. Ul’trastrukturnye izmeneniâ v organah morskih svinok pri posledovatel’nom passirovanii virusa Èbola. Vopr Virusol 38, 179–182 (1993).

    CAS  Google Scholar 

  34. 34.

    Ryabchikova, E. et al. Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch Virol 141, 909–921 (1996).

    Article  CAS  Google Scholar 

  35. 35.

    Ryabchikova, E. I., Smolina, M., Grajdantseva, A. & Rassadkin, J. In Ebola and Marburg viruses. Molecular and cellular biology (eds Heinz-Dieter Klenk & Heinz Feldmann) 239–254 (Horizon Bioscience, 2004).

  36. 36.

    Wong, G. et al. Ebola virus transmission in guinea pigs. J Virol 89, 1314–1323, (2015).

    Article  CAS  Google Scholar 

  37. 37.

    Marzi, A. Evaluation of Ebola virus countermeasures in guinea pigs. Methods Mol Biol 1628, 283–291, (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Twenhafel, N. A. et al. Experimental aerosolized guinea pig-adapted Zaire ebolavirus (variant: Mayinga) causes lethal pneumonia in guinea pigs. Vet Pathol 52, 21–25, (2015).

    Article  CAS  Google Scholar 

  39. 39.

    Ryabchikova, E., Strelets, L., Kolesnikova, L., Pyankov, O. & Sergeev, A. Respiratory Marburg virus infection in guinea pigs. Arch Virol 141, 2177–2190 (1996).

    Article  CAS  Google Scholar 

  40. 40.

    Thoolen, B. et al. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38, 5S–81S, (2010).

    Article  Google Scholar 

  41. 41.

    Cheresiz, S. V., Semenova, E. A. & Chepurnov, A. A. Adapted lethality: what we can learn from guinea pig-adapted Ebola virus infection model. Adv Virol 2016, 8059607, (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. 42.

    McConnell, E. E. & Talley, F. A. Intracytoplasmic hyaline globules in the adrenal medulla of laboratory animals. Vet Pathol 14, 335–340 (1977).

    Article  CAS  Google Scholar 

  43. 43.

    Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E. & Zaki, S. R. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 235, 153–174, (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Billioux, B. J. et al. Cerebrospinal Fluid Examination in Survivors of Ebola Virus Disease. JAMA Neurol 74, 1141–1143, (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Sagui, E. et al. Severe Ebola virus infection with encephalopathy: evidence for direct virus involvement. Clin Infect Dis 61, 1627–1628, (2015).

    Article  Google Scholar 

  46. 46.

    Cross, R. W. et al. Comparison of the pathogenesis of the Angola and Ravn strains of Marburg virus in the outbred guinea pig model. J Infect Dis 212(Suppl 2), S258–270, (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Vetter, P. et al. Ebola virus shedding and transmission: review of current evidence. J Infect Dis 214, S177–S184, (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Ward, J. M., Lock, A., Collins, M. J. Jr., Gonda, M. A. & Reynolds, C. W. Papovaviral sialoadenitis in athymic nude rats. Lab Anim 18, 84–89, (1984).

    Article  CAS  Google Scholar 

  49. 49.

    Hviid, A., Rubin, S. & Muhlemann, K. Mumps. Lancet 371, 932–944, (2008).

    Article  Google Scholar 

  50. 50.

    Besch-Williford, C. et al. A naturally transmitted epitheliotropic polyomavirus pathogenic in immunodeficient rats: characterization, transmission, and preliminary epidemiologic studies. Toxicol Pathol 45, 593–603, (2017).

    Article  CAS  Google Scholar 

  51. 51.

    Larsen, T. et al. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis 196(Suppl 2), S323–328, (2007).

    Article  Google Scholar 

  52. 52.

    Geisbert, T. W. et al. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant proteinc2. J Infect Dis 196(Suppl 2), S372–381, (2007).

    Article  CAS  Google Scholar 

  53. 53.

    Geisbert, T. W. & Jaax, N. K. Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. Ultrastruct Pathol 22, 3–17 (1998).

    Article  CAS  Google Scholar 

Download references


The content of this publication does not necessarily reflect the views or policies of the US Department of the Army, the US Department of Defense, or the US Department of Health and Human Services or of the institutions and companies affiliated with the authors. This work was funded in part through Battelle Memorial Institute’s prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272200700016I. J.C.J. and J.H.K. performed this work as employees of Battelle Memorial Institute. Subcontractors to Battelle Memorial Institute who performed this work are: T.K.C., L.H., O.R., A.B., R.H., and S.Y., employees of Charles River Laboratories. The authors thank Dr. Thomas W. Geisbert (University of Texas Medical Branch, Galveston, TX, USA) for the kind gift of Ebola virus/UTMB/C.porcellus-lab/COD/1976/Yambuku-Mayinga-GPA. The authors would like to thank IRF-Frederick staff Jiro Wada for figure preparation and Dr. Donna Perry and Laura Bollinger for critically reviewing and editing the manuscript.

Author information




Conceptualization: T.K.C., J.C.J., P.B.J., J.H.K., X.Z.; Methodology: T.K.C., L.H., J.C.J., O.R., S.Y., A.B., R.H., X.Z.; Formal analysis: T.K.C., X.K.; Writing - original draft: T.K.C., J.H.K.; Writing - review & editing: all authors; Supervision: M.G.S., S.B., P.B.J.; Project administration: J.C.J.; Funding acquisition: P.B.J.

Corresponding authors

Correspondence to Timothy K. Cooper or Xiankun Zeng.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cooper, T.K., Huzella, L., Johnson, J.C. et al. Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model. Sci Rep 8, 1250 (2018).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing